The pharmaceutical industry is a natural hunting ground for reliable income stocks, since people buy drugs in good times and in bad. But which high-yield dividend stocks are actually worthy of your investment dollars? We posed that question to a team of Motley Fool healthcare investors, and they picked Pfizer (NYSE: PFE), GlaxoSmithKline (NYSE: GSK), and Novo Nordisk (NYSE: NVO).